S.Amdt. 5391Senate117th Congress (2021-2023)2nd degree
S.Amdt. 5391
Sponsored by
Sen. Roger Marshall (R-KS)
Submitted August 6, 2022
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
August 6, 2022
Text
Submitted
SA 5391. Mr. MARSHALL submitted an amendment intended to be proposed to amendment SA 5194 proposed by Mr. Schumer to the bill H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; which was ordered to lie on the table; as follows: At the end of part 1 of subtitle B of title I, add the following: SEC. 11005. CONSULTATION REQUIREMENT. As a condition of implementing the provisions of, including the amendments made by, section 11001 and 11002, the Government Accountability Office shall to submit a report to Congress with recommendations to ensure that the implementation of such provisions does not-- (1) negatively impact the United States pharmaceutical industry market competitiveness with China regarding biopharmaceutical innovation and domestic manufacturing capacity; or (2) increase the United States' current importation levels of essential generic drugs and drugs on the FDA shortages list that are produced or manufactured by foreign entities in China. ______